Kangjie Medical Reports 2019 Net Profit of RMB 3.48 Million, Up 29.50%, Driven by Increased Sales Revenue

Source: Wabei.com

Wabei.com, April 24 – According to the 2019 annual report recently released by Kangjie Medical (430521), as of December 31, 2019, the company’s operating revenue for 2019 amounted to RMB 56,250,257.61, representing a year-on-year increase of 10.53%; the net profit attributable to shareholders of the listed company was RMB 3,482,600.24, up 29.50% from the previous year; and basic earnings per share stood at RMB 0.11, marking a 37.50% increase compared to the same period last year.

As of December 31, 2019, the total assets of Kangjie Medical amounted to RMB 82,094,911.32, representing an increase of 18.07% compared to the end of the previous year; the net cash flow from operating activities for the current period was RMB -2,775,401.37, compared to RMB 1,230,754.53 in the same period of the previous year.

Operating revenue for the current period amounted to RMB 56.2503 million, representing a 10.53% increase compared to the same period last year. The change was primarily driven by higher market acceptance of the Company’s independently developed products following their upgrade and iteration, which led to an increase in sales revenue.

According to data from the Wabei New Third Board Research Institute, Kangjie Medical is primarily engaged in the research and development, production, and sales of ophthalmic medical devices, including slit lamp microscopes, retinoscopes, and ophthalmoscopes.